Cue Biopharma, Inc. Capital Expenditures
Cue Biopharma, Inc. (CUE) reported Capital Expenditures of $121.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $121.00K, a 19.33% decline year-over-year.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $177.00K, a 168.18% increase from fiscal 2024.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $66.00K.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Cue Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $171.00K, a 81.27% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $121.00K 10-Q · filed 2026-08-14 | $121.00K derived: sum of 3 quarters · filed 2026-08-14 | $121.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $121.00K 10-Q · filed 2026-05-14 | $121.00K derived: sum of 2 quarters · filed 2026-05-14 | $121.00K derived: sum of 3 quarters · filed 2026-05-14 | $148.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $27.00K derived: sum of 3 quarters · filed 2026-08-14 | $177.00K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $27.00K derived: sum of 2 quarters · filed 2026-08-14 | $177.00K 10-Q · filed 2025-11-12 | $179.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $177.00K 10-Q · filed 2026-08-14 | $179.00K derived: sum of 3 quarters · filed 2026-08-14 | $178.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $150.00K 10-Q · filed 2026-05-14 | $152.00K derived: sum of 2 quarters · filed 2026-05-14 | $151.00K derived: sum of 3 quarters · filed 2026-05-14 | $161.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.00K derived: sum of 2 quarters · filed 2026-03-16 | $11.00K derived: sum of 3 quarters · filed 2026-03-16 | $66.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.00K derived: sum of 2 quarters · filed 2025-11-12 | $64.00K 10-Q · filed 2025-11-12 | $64.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $65.00K 10-Q · filed 2025-08-12 | $65.00K derived: sum of 3 quarters · filed 2025-08-12 | $65.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $55.00K 10-Q · filed 2025-05-12 | $55.00K derived: sum of 2 quarters · filed 2025-05-12 | $55.00K derived: sum of 3 quarters · filed 2025-05-12 | $55.00K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $1.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $1.00K derived: sum of 3 quarters · filed 2024-08-14 | $79.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $1.00K derived: sum of 2 quarters · filed 2024-05-09 | $79.00K derived: sum of 3 quarters · filed 2024-05-09 | $144.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $79.00K derived: sum of 2 quarters · filed 2024-03-28 | $144.00K derived: sum of 3 quarters · filed 2024-03-28 | $171.00K 10-K · filed 2024-03-28 | $170.75K 10-K · filed 2023-03-21 |
| 2022-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $143.00K derived: sum of 2 quarters · filed 2023-11-03 | $170.00K 10-Q · filed 2023-11-03 | $170.04K derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $92.00K 10-Q · filed 2023-08-08 | $92.04K derived: sum of 3 quarters · filed 2023-08-08 | $105.04K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $27.00K 10-Q · filed 2023-05-09 | $27.04K derived: sum of 2 quarters · filed 2023-05-09 | $40.04K derived: sum of 3 quarters · filed 2023-05-09 | $292.04K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $39.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $13.04K derived: sum of 2 quarters · filed 2023-03-21 | $265.04K derived: sum of 3 quarters · filed 2023-03-21 | $913.04K 10-K · filed 2023-03-21 | |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $265.00K derived: sum of 2 quarters · filed 2022-11-14 | $913.00K 10-Q · filed 2022-11-14 | $1.02M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $900.00K 10-Q · filed 2022-08-04 | $1.01M derived: sum of 3 quarters · filed 2022-08-04 | $1.35M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $648.00K 10-Q · filed 2022-05-10 | $756.26K derived: sum of 2 quarters · filed 2022-05-10 | $1.10M derived: sum of 3 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $108.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $454.26K derived: sum of 2 quarters · filed 2022-03-16 | $595.26K 10-K · filed 2022-03-16 | ||
| 2020-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $487.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $141.00K 10-Q · filed 2021-08-09 | ||||
| 2019-12-31 | $10.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $27.35K derived: sum of 2 quarters · filed 2021-03-09 | $27.35K derived: sum of 3 quarters · filed 2021-03-09 | $46.35K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $17.00K derived: sum of 2 quarters · filed 2020-11-09 | $36.00K 10-Q · filed 2020-11-09 | $156.25K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $19.00K 10-Q · filed 2020-08-07 | $139.25K derived: sum of 3 quarters · filed 2020-08-07 | $440.25K derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | $19.00K 10-Q · filed 2020-05-07 | $139.25K derived: sum of 2 quarters · filed 2020-05-07 | $440.25K derived: sum of 3 quarters · filed 2020-05-07 | $1.20M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $120.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $421.25K derived: sum of 2 quarters · filed 2020-03-12 | $1.18M derived: sum of 3 quarters · filed 2020-03-12 | $1.85M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.06M derived: sum of 2 quarters · filed 2019-11-07 | $1.73M 10-Q · filed 2019-11-07 | $1.75M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.43M 10-Q · filed 2019-08-08 | $1.45M derived: sum of 3 quarters · filed 2019-08-08 | $1.66M derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $673.00K 10-Q · filed 2019-05-08 | $691.94K derived: sum of 2 quarters · filed 2019-05-08 | $899.94K derived: sum of 3 quarters · filed 2019-05-08 | $1.15M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $18.94K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $226.94K derived: sum of 2 quarters · filed 2019-03-14 | $473.94K derived: sum of 3 quarters · filed 2019-03-14 | $1.03M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $455.00K derived: sum of 2 quarters · filed 2018-11-13 | $1.01M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $247.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $803.00K 10-Q · filed 2018-08-13 | |||
| 2017-03-31 | $556.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |